🟢 Milestone Pharmaceuticals is trading 5.33% up in after-hours trading with no clear catalyst identified

Milestone Pharmaceuticals is trading 5.33% up at $1.00 after-hours, with no clear catalyst identified.

• This compares with the September 14 regular-session close of $0.95; no new company-specific announcement or analyst action was identified for September 14, 2026.
• The September 15 H.C. Wainwright presentation is scheduled for 10:30 a.m. ET, but available information does not establish it as the after-hours catalyst.
• The broader market was modestly weaker, providing no clear directional explanation.